期刊文献+

慢病毒介导的RNAi对卵巢癌细胞增殖及间皮素表达的影响 被引量:5

Lentivirus mediated RNA interference inhibits mesothelin expression in ovarian cancer cells and cell proliferation
下载PDF
导出
摘要 目的:构建间皮素(mesothelin,MSLN)RNAi重组慢病毒质粒,探讨其对卵巢癌OVCAR-3细胞MSLN的表达及细胞增殖的影响。方法:根据MSLN基因信息,设计了4个小干扰序列和1个阴性对照序列,利用慢病毒质粒载体pRNAT-U6.2/Lenti构建了5个重组质粒并进行了慢病毒包装,分别为LV-MSLN-negative、LV-MSLN-shRNA2、LV-MSLN-shRNA3、LV-MSLN-shRNA4;感染OVCAR-3细胞后,Westernblotting和荧光免疫组化检测干扰效率,选择干扰效率高的质粒载体进行慢病毒大量包装;感染卵巢癌细胞OVCAR-3后,用细胞增殖实验和平板克隆形成实验检测细胞增殖的变化。结果:测序结果证明5种质粒载体的插入序列完全正确,鉴定证明慢病毒包装成功。慢病毒感染OVCAR-3细胞后,Westernblotting证实重组慢病毒LV-MSLN-shRNA4的干扰效率最高,对MSLN蛋白表达的抑制达90%。荧光免疫组化的共聚焦照片显示干扰组(OVC-shRNA)定位于细胞膜的MSLN蛋白表达明显弱于阴性对照组(OVC-neg)和空白对照组(OVC)。OVC-shRNA组细胞增殖[(11.2±1.3)×105]显著慢于OVC-neg组[(20.5±2.5)×105]和OVC组[(21.9±2.3)×105](P<0.05)。OVC-shRNA组克隆形成率为(15.2±2.1)%,明显低于OVC-neg组[(27.9±2.5)%]和OVC组[(28.8±3.1)%](P<0.05)。结论:成功构建MSLNRNAi重组慢病毒质粒LV-MSLN-shRNA4,它能有效抑制卵巢癌OVCAR-3细胞的MSLN表达及细胞增殖,为进一步研究MSLN应用于肿瘤基因治疗奠定了基础。 Objective:To construct a recombinant lentivirus plasmid of RNA interference targeting (MSLN) gene and to observe its effect on MSLN expression in human ovarian cancer cell line OVCAR-3 and its effect on cell proliferation. Methods: According to the Genbank information of MSLN, four RNA interfering sequences and a negative sequence were designed and inserted into plasmid pRNAT-U6.2/Lenti and 5 kinds of plasmids were packaged: LV-MSLN-negative,LV-MSLN-shRNA1, LV-MSLN-shRNA2, LV-MSLN-shRNA3, and LV-MSLN-shRNA4; and they were used to transfect OVCAR-3 cells. Western blotting and indirect immunofluorescence were then used to investigate the interfering efficiency. The plasmid with high interfering efficiency was packaged. The cell proliferation test and clone-forming test was used to assess the changes in cell proliferation. Results: DNA sequencing showed that the sequences of 5 recombinant lentivirus plasmids were correct. Lentivirus packaging was successfully done. Western blotting analysis confirmed that LV-MSLN-shRNA4 had the highest interfering efficiency (90%). MSLN specifically bound to cytomembrane of OVCAR-3 cells. Expression of MSLN in the interfered cells (OVC-shRNA) was weaker than that in the control cells (OVC-neg,OVC). OVC-shRNA cells([11.2±1.3]×10^5) grew slowly compared to OVC-neg cells([20.5±2.5]×10^5) and OVC cells([21.9±2.3]×10^5) (P〈0.05). There was a significant reduction in clone forming rate of OVC-shRNA cells (15.2±2.1)% in comparison with OVC-neg cells([27.9±2.5]%) and OVC cells([28.8±3.1]%)(P〈0.05).Conclusions: We have successfully constructed MSLN RNAi recombination plasmid LV-MSLN-shRNA4, which can effectively inhibit MSLN expression and cell proliferation, which paves a way for studying MSLN function and gene therapy.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2008年第2期134-138,共5页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No30572093) 河北省自然科学基金资助项目(NoC2005000804)~~
关键词 间皮素 RNA干扰 慢病毒 卵巢肿瘤 细胞增殖 mesothelin RNA interference lentivirus ovarian neoplasms cell proliferation
  • 相关文献

参考文献17

  • 1吴小华,王小玲,张立芳,李利,王永军,郭燕红,郭清,杨波,黎海莉.卵巢上皮性肿瘤组织中间皮素和CA_(125)表达及其相关性研究[J].中华妇产科杂志,2005,40(10):709-711. 被引量:16
  • 2Filpula D, Yang K, Basu A, et al. Releasable PEGylation of mesothelin targeted immunotoxin SS1 P achieves single dosage complete regression of a human carcinoma in mice [ J ]. Bioconjug Chem,2007,18 ( 3 ) :773-784. 被引量:1
  • 3Hung CF, Calizo R, Tsai YC, et al. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors[J]. Vaccine, 2007, 25( 1 ) : 127-135. 被引量:1
  • 4Hassan R, Remaley AT, Sampson ML, et al. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer[ J]. Clin Cancer Res, 2006,12 (2) :447-453. 被引量:1
  • 5Huang CY, Cheng WF, Lee CN, et al. Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor[J]. Anticancer Res,2006,26(6C) :4721-4728. 被引量:1
  • 6陈书成,刘雅坤,吴小华,单保恩,陈兴,孙东霞,王莉.抗人可溶性间皮素相关蛋白单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2007,23(3):246-248. 被引量:5
  • 7Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers[J]. Proc Natl Acad Sci USA,1996, 93( 1 ) :136-140. 被引量:1
  • 8Ordonez NG. Value of mesothelin immunostaining in the diagnosis of mesothelioma[ J ]. Mod Pathol,2003,16( 3 ) : 192-197. 被引量:1
  • 9Hassan R, Kreitman R J, Pastan I, et al. Localization of mesothelin in epithelial ovarian cancer [ J ]. Appl Immunohistochern Mol Morphol,2005,13 ( 3 ) :243-247. 被引量:1
  • 10Shaw DR, Muminova ZE, Strong TV. Mesothelin : a new target for immunotherapy[ J]. Clin Cancer Res,2004,10( 15 ) :3937-3942. 被引量:1

二级参考文献14

  • 1陈玉珍,何韶衡,周艳春,黄阗,刘岳宁,陈霖霏.抗人分泌性白细胞蛋白酶抑制剂单克隆抗体的制备与鉴定[J].细胞与分子免疫学杂志,2006,22(1):54-57. 被引量:2
  • 2Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci USA, 1996, 93:136-140. 被引量:1
  • 3Hassan R, Bera T, Pastan I. Mesothelin: a new target for immunotherapy. Clin Cancer Res, 2004, 10: 3937-3942. 被引量:1
  • 4Rump A, Morikawa Y, Tanaka M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem, 2004, 279:9190-9198. 被引量:1
  • 5Frierson HF Jr, Moskaluk CA, Powell SM, et al. Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. Hum Pathol, 2003, 34:605-609. 被引量:1
  • 6Ordonez NG. Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol, 2003, 27:1418-1428. 被引量:1
  • 7Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology, 2001, 38:87-95. 被引量:1
  • 8O'Brien TJ, Beard JB, Underwood LJ, et al. The CA125 gene: an extracellular superstructure dominated by repeat sequences. Tumour Biol, 2001, 22: 348-366. 被引量:1
  • 9Chang K,Pai LH,Pass H,et al.Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma[J].Am J Surg Pathol,1992,16(3):259-268. 被引量:1
  • 10Chang K,Pastan I.Molecular cloning of mesothelin,a differentiation antigen present on mesothelium,mesothelioma,and ovarian cancers[J].Proc Natl Acad Sci USA,1996,93(1):136-140. 被引量:1

共引文献18

同被引文献39

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部